Michael A. Panzara, Franchise Lead, Neurology at WAVE Life Sciences Ltd. (WVE), sold 14,828 shares at $16.67 ($247K) on 2017-07-12, disclosed to the SEC on 2017-07-13.
Open-market sale of $247k WVE by Franchise Lead, Neurology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.67 | 7,414 | $124K | 50.0% |
| 2 | $16.67 | 7,414 | $124K | 50.0% |
| Total | $16.67 avg | 14,828 | $247K | 100% |
| Filing → |
| WVE | SELL | 2021-02-18 | $31K | — | Filing → |
| WVE | SELL | 2020-02-20 | $23K | — | Filing → |
| WVE | SELL | 2019-07-09 | $153K | — | Filing → |